Market Research Logo

Tunisia Pharmaceuticals and Healthcare Report Q4 2017

Tunisia Pharmaceuticals and Healthcare Report Q4 2017

BMI View: Tunisia's pharmaceutical market will continue to be met with challenges that ensuremultinational drugmakers remain wary of significant investment plans. A progressively improving businessclimate is having a notable impact on developments within the pharmaceutical sector and wider economy;however, the actual benefits will take time to materialise. Crucially, higher growth opportunities willpresent themselves within the generic medicines sector, while the high industry-associated risk profile willdeter any significant investment by multinational firms.

Headline Expenditure Projections

Pharmaceuticals: TND1.95bn (USD909mn) in 2016 to TND2.14bn (USD895mn) in 2017; +9.6%growth in local currency terms and -1.4% in US dollar terms.

Healthcare: TND6.5bn (USD3.0bn) in 2016 to TND6.9 (USD2.9bn) in 2017; +6.0% growth in localcurrency terms and -4.7% in US dollar terms.

Latest Updates

Merck KGaA announced in July 2017 that it plans to roll out an innovative healthcare initiative inTunisia by 2019 - following its launch in Kenya in 2016.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Tunisia) (2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Tunisia 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Tunisia 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Tunisia 2013-2021)
Industry Risk/Reward Index
MENA Pharmaceuticals & Healthcare Risk/Reward Index
Regulatory Development
Regulatory Review
Pricing And Reimbursement Regime
Market Overview
Healthcare Sector
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Generic Drugmakers
Demographic Forecast
Table: Population Headline Indicators (Tunisia 1990-2025)
Table: Key Population Ratios (Tunisia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Tunisia 1990-2025)
Table: Population By Age Group (Tunisia 1990-2025)
Table: Population By Age Group % (Tunisia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report